NCT03523897

A Prospective Study to Evaluate Robot Assisted Total Knee Replacement Outcomes

Terminated NA Results posted Last updated 6 June 2025

What this trial tests

NA trial testing Robot Assisted Total Knee Replacement in Primary Osteoarthritis of Knee Nos in 92 participants. Terminated before completion.

Timeline

20 April 2018

Primary endpoint
14 July 2022

14 July 2022

Quick facts

Lead sponsor	Virtua Health, Inc.
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	basic science
Enrollment	92
Start date	20 April 2018
Primary completion	14 July 2022
Estimated completion	14 July 2022
Sites	1 location across United States

Drugs / interventions tested

• Robot Assisted Total Knee Replacement
• Traditional Total Knee Replacement

Conditions studied

• Primary Osteoarthritis of Knee Nos — all drugs for Primary Osteoarthritis of Knee Nos →

Sponsor

Virtua Health, Inc. — full company profile →

Who can join

18 and older, any sex, with Primary Osteoarthritis of Knee Nos. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to see if outcomes for patients that receive the traditional total knee replacement surgical technique are different than the outcomes for patients that receive robot-assisted total knee replacement. The outcomes we will be tracking include:

1. Patients' self-reported awareness of their artificial joints during activities of daily living;
2. Patient's self-reported pain, other symptoms, function in daily living, function in sport and recreation, and knee-related quality of life;
3. Patients' self-reported general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy-fatigue, social functioning and mental health;
4. The accuracy of implant placement and limb alignment

Publications & conference data

No peer-reviewed publications indexed yet for this trial.